Arecor Therapeutics plc (AIM:AREC)
London · Delayed Price · Currency is GBP · Price in GBX 66.50
+4.00 (6.40%)
At close: Mar 25, 2026
Arecor Therapeutics Market Cap
Arecor Therapeutics has a market cap or net worth of 25.11 million as of March 25, 2026. Its market cap has increased by 31.68% in one year.
Market Cap
25.11M
Enterprise Value
23.40M
Revenue
5.06M
Ranking
n/a
PE Ratio
n/a
Stock Price
66.50
Market Cap Chart
Since June 3, 2021, Arecor Therapeutics's market cap has decreased from 66.99M to 25.11M, a decrease of -62.52%. That is a compound annual growth rate of -18.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 25.11M | -17.39% |
| Dec 31, 2025 | 30.39M | 9.52% |
| Dec 31, 2024 | 27.75M | -50.35% |
| Dec 29, 2023 | 55.89M | -23.94% |
| Dec 30, 2022 | 73.48M | -34.00% |
| Dec 31, 2021 | 111.34M | 66.19% |
| Jun 3, 2021 | 66.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ondine Biomedical | 55.85M |
| Faron Pharmaceuticals Oy | 49.79M |
| hVIVO | 46.61M |
| Poolbeg Pharma | 29.09M |
| ImmuPharma | 24.63M |
| Sareum Holdings | 21.40M |
| SkinBioTherapeutics | 20.34M |
| Aptamer Group | 18.88M |